GlassScriptPhysician profile
Maxwell V Meng
NPI 1801824024
$67,347.40
in general payments reported to CMS, 2019-2025
6 companies · $29K in 2025
The $29K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,230 · 2020: $922 · 2021: $6,662 · 2022: $2,070 · 2023: $27K · 2024: $152 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Education: $3,000 · Food and Beverage: $152 · Gift: $94.57 · Travel and Lodging: $70.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,147.59 |
| Education | $3,000.00 |
| Food and Beverage | $151.61 |
| Gift | $94.57 |
| Travel and Lodging | $70.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $53,725.48 | 2019-2025 | Da Vinci Surgical System |
| Ethicon INC. | $13,051.28 | 2019-2023 | |
| Genentech, INC. | $250.00 | 2020 | |
| Photocure INC | $169.03 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $151.61 | 2024 | Bard Urinary Drainage Bag |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxwell Meng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.